Archives

Monthly Archive for: "January, 2021"

Home /

By Jane Moate

In News

Posted 20th January 2021

Dr Steve Pawsey, CMO at NeRRe Therapeutics to Present at The Eleventh International Cough Symposium

By Jane Moate

In News

Posted 12th January 2021

Dr Mary Kerr, CEO of NeRRe Therapeutics to present at Biotech Showcase

NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.

Useful Links

Contact Us
About Us
Privacy Policy
Cookie Notice
Terms & Conditions
Clinical Trials Privacy Notice

Please fill out the form to get in touch with us.

I consent to NeRRe Therapeutics collecting my details through this form.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies Enabled Disabled

Cookie Policy

More information about our Cookie Policy